eISSN: 1897-4317
ISSN: 1895-5770
Gastroenterology Review/Przegląd Gastroenterologiczny
Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
4/2011
vol. 6
 
Share:
Share:
abstract:
Review paper

Osteoprotegerin, receptor activator of nuclear factor kB and receptor activator of nuclear factor κB ligand and bone mineralization in children with inflammatory bowel diseases

Agnieszka Jankowska
,
Anna Korzon-Burakowska
,
Barbara Kamińska

Przegląd Gastroenterologiczny 2011; 6 (4): 213–217
Online publish date: 2011/09/06
View full text Get citation
 
PlumX metrics:
Morbidity of inflammatory bowel diseases (IBD) has been increasing in children recently. The pathogenesis of these autoimmune diseases still remains unknown, so the therapy of IBD is mainly symptomatic. Chronic inflammation and applied treatment involve many complications, among which impaired bone mineralization is quite common. Great expectations arose when three cytokines were explored: osteoprotegerin (OPG), receptor activator of nuclear factor kB (RANK) and receptor activator of nuclear factor κB ligand (RANKL). These molecules were identified in many cells and play a key role in bone formation and resorption, as well as in the immune system. Due to increasing knowledge about these cytokines there are new possibilities for treatment of the diseases in which OPG, RANK and RANKL are engaged.
keywords:

inflammatory bowel diseases, osteoprotegerin, children

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.